Ganoderma lucidum Polysaccharides: Immunomodulation and Potential Anti-Tumor Activities
Authors:
- 1 January 2011
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 39 (01) , 15-27
Abstract
Ganoderma lucidum (G. lucidum), a basidiomycete white rot fungus, has long been prescribed to prevent and treat various human diseases, particularly in China, Japan, and Korea. Several classes of bioactive substances have been isolated and identified from G. lucidum, such as triterpenoids, polysaccharides, nucleosides, sterols, and alkaloids, among others. This paper examines the potential role of G. lucidum polysaccharide (GLPS) in tumor therapy and the possible mechanisms involved. Both in vitro and in vivo studies suggested that the anti-tumor activities of GLPS are mediated by its immunomodulatory, anti-angiogenic, and cytotoxic effects. GLPS affects immune cells and immune-related cells including B lymphocytes, T lymphocytes, dendritic cells, macrophages, and natural killer cells. In addition, recent data also suggest that GLPS suppresses tumorigenesis or inhibits tumor growth through direct cytotoxic effect and anti-angiogenic actions. However, many questions still need to be answered before both G. lucidum and GLPS can be widely accepted and used as anti-tumor agents.Keywords
This publication has 37 references indexed in Scilit:
- Expansion and Activation of Natural Killer Cells for Cancer ImmunotherapyAnnals of Laboratory Medicine, 2009
- Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory functionJournal of Hematology & Oncology, 2008
- Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network constructionBMC Genomics, 2007
- Ganoderma – A therapeutic fungal biofactoryPhytochemistry, 2006
- Polysaccharide Purified from Ganoderma lucidum Induces Gene Expression Changes in Human Dendritic Cells and Promotes T Helper 1 Immune Response in BALB/c MiceMolecular Pharmacology, 2006
- Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cellLife Sciences, 2006
- Antitumor Activity and Underlying Mechanisms of Ganopoly, The Refined Polysaccharides Extracted from Ganoderma Lucidum, in MiceImmunological Investigations, 2005
- Immune receptors for polysaccharides from Ganoderma lucidumBiochemical and Biophysical Research Communications, 2004
- Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidumBritish Journal of Pharmacology, 2003
- Isoflavone Aglycon Produced by Culture of Soybean Extracts with Basidiomycetes and Its Anti-angiogenic ActivityBioscience, Biotechnology, and Biochemistry, 2002